Clinical Trial Update: A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites [NA]

View source ↗

Summary

This clinical trial update reports the completion of a multicenter, prospective, open-label feasibility study evaluating the safety and effectiveness of an auto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis

Snippet

Sponsor: Sequana Medical N.V. | Conditions: Cirrhosis, Ascites | NA | Status: COMPLETED